Patents by Inventor Anthony RODGERS

Anthony RODGERS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260256754
    Abstract: Provided herein are pharmaceutical compositions that are useful for the treatment of hypertension comprising an angiotensin II receptor blocker, a diuretic, and a calcium channel blocker.
    Type: Application
    Filed: May 11, 2026
    Publication date: September 3, 2026
    Inventors: Anthony RODGERS, Stephen MACMAHON
  • Patent number: 12673047
    Abstract: Provided herein are pharmaceutical compositions that are useful for the treatment of hypertension comprising an angiotensin II receptor blocker, a diuretic, and a calcium channel blocker.
    Type: Grant
    Filed: September 26, 2025
    Date of Patent: July 7, 2026
    Assignee: THE GEORGE INSTITUTE FOR GLOBAL HEALTH
    Inventors: Anthony Rodgers, Stephen Macmahon
  • Patent number: 12661345
    Abstract: Provided herein are pharmaceutical compositions that are useful for the treatment of hypertension comprising an angiotensin II receptor blocker, a diuretic, and a calcium channel blocker.
    Type: Grant
    Filed: November 11, 2025
    Date of Patent: June 23, 2026
    Assignee: THE GEORGE INSTITUTE FOR GLOBAL HEALTH
    Inventors: Anthony Rodgers, Stephen MacMahon
  • Publication number: 20260166019
    Abstract: Provided herein are pharmaceutical compositions that are useful for the treatment of hypertension comprising an angiotensin II receptor blocker, a diuretic, and a calcium channel blocker.
    Type: Application
    Filed: July 1, 2025
    Publication date: June 18, 2026
    Inventors: Anthony RODGERS, Stephen MACMAHON
  • Publication number: 20260124187
    Abstract: Provided herein are pharmaceutical compositions that are useful for the treatment of hypertension comprising an angiotensin II receptor blocker, a diuretic, and a calcium channel blocker, wherein the dose of each component is below the lowest dose approved for the treatment of hypertension for the component.
    Type: Application
    Filed: November 7, 2025
    Publication date: May 7, 2026
    Inventors: Anthony RODGERS, Stephen MACMAHON
  • Publication number: 20260060968
    Abstract: Provided herein are pharmaceutical compositions that are useful for the treatment of hypertension comprising an angiotensin II receptor blocker, a diuretic, and a calcium channel blocker.
    Type: Application
    Filed: November 11, 2025
    Publication date: March 5, 2026
    Inventors: Anthony RODGERS, Stephen MACMAHON
  • Publication number: 20260027093
    Abstract: Provided herein are pharmaceutical compositions that are useful for the treatment of hypertension comprising an angiotensin II receptor blocker, a diuretic, and a calcium channel blocker.
    Type: Application
    Filed: September 26, 2025
    Publication date: January 29, 2026
    Inventors: Anthony RODGERS, Stephen MACMAHON
  • Patent number: 12521380
    Abstract: Provided herein are pharmaceutical compositions that are useful for the treatment of hypertension comprising an angiotensin II receptor blocker, a diuretic, and a calcium channel blocker.
    Type: Grant
    Filed: March 7, 2025
    Date of Patent: January 13, 2026
    Assignee: THE GEORGE INSTITUTE FOR GLOBAL HEALTH
    Inventors: Anthony Rodgers, Stephen Macmahon
  • Publication number: 20250347885
    Abstract: A protective body 800 is provided to protect a spliced joint (912) between two optical fibres. The protective body is small, robust and streamlined so that the cable including the spliced joint can be installed in a microduct, for example by blowing. A pre-terminated cable assembly (1000, 1200) comprises a length of cable (1110, 1210) in which one or more optical fibres (306) are embedded in a coated fibre bundle. An extruded sheath (324) covers the coated fibre bundle. A ferrule sub-assembly (1124a, 1224a) is pre-arranged on a leading end of the cable. After passing through a duct, the sub-assembly (1124a, 1224a) becomes part of a pluggable connector (500). For the manufacture of such cable assemblies, a supply (1152) of pre-terminated fibre “tails” is made. These tails are then spliced to the ends of a longer cable, to form the cable complete assembly of desired length.
    Type: Application
    Filed: May 11, 2023
    Publication date: November 13, 2025
    Applicant: EMTELLE UK LIMITED
    Inventors: Anthony RODGERS, Eben Colin KIRKPATRICK, Jean-Pierre TERBLANCHE, Morten JENSEN
  • Patent number: 12465599
    Abstract: Provided herein are pharmaceutical compositions that are useful for the treatment of hypertension comprising an angiotensin II receptor blocker, a diuretic, and a calcium channel blocker.
    Type: Grant
    Filed: April 1, 2025
    Date of Patent: November 11, 2025
    Assignee: THE GEORGE INSTITUTE FOR GLOBAL HEALTH
    Inventors: Anthony Rodgers, Stephen Macmahon
  • Publication number: 20250312325
    Abstract: Provided herein are pharmaceutical compositions that are useful for the treatment of hypertension comprising an angiotensin II receptor blocker, a diuretic, and a calcium channel blocker.
    Type: Application
    Filed: April 1, 2025
    Publication date: October 9, 2025
    Inventors: Anthony RODGERS, Stephen MACMAHON
  • Publication number: 20250205210
    Abstract: Provided herein are pharmaceutical compositions that are useful for the treatment of hypertension comprising an angiotensin II receptor blocker, a diuretic, and a calcium channel blocker.
    Type: Application
    Filed: March 7, 2025
    Publication date: June 26, 2025
    Inventors: Anthony RODGERS, Stephen MACMAHON
  • Patent number: 12285415
    Abstract: Provided herein are pharmaceutical compositions that are useful for the treatment of hypertension comprising an angiotensin II receptor blocker, a diuretic, and a calcium channel blocker.
    Type: Grant
    Filed: August 8, 2023
    Date of Patent: April 29, 2025
    Assignee: THE GEORGE INSTITUTE FOR GLOBAL HEALTH
    Inventors: Anthony Rodgers, Stephen Macmahon
  • Patent number: 12102623
    Abstract: Provided herein are pharmaceutical compositions that are useful for the treatment of hypertension comprising an angiotensin II receptor blocker, a diuretic, and a calcium channel blocker.
    Type: Grant
    Filed: September 16, 2022
    Date of Patent: October 1, 2024
    Assignee: THE GEORGE INSTITUTE FOR GLOBAL HEALTH
    Inventors: Anthony Rodgers, Stephen MacMahon
  • Publication number: 20230381161
    Abstract: Provided herein are pharmaceutical compositions that are useful for the treatment of hypertension comprising an angiotensin II receptor blocker, a diuretic, and a calcium channel blocker.
    Type: Application
    Filed: August 8, 2023
    Publication date: November 30, 2023
    Inventors: Anthony RODGERS, Stephen MACMAHON
  • Publication number: 20230125076
    Abstract: Provided herein are pharmaceutical compositions that are useful for the treatment of hypertension comprising an angiotensin II receptor blocker, a diuretic, and a calcium channel blocker.
    Type: Application
    Filed: December 16, 2022
    Publication date: April 27, 2023
    Inventors: Anthony RODGERS, Stephen MACMAHON
  • Publication number: 20230087834
    Abstract: Provided herein are pharmaceutical compositions that are useful for the treatment of hypertension comprising an angiotensin II receptor blocker, a diuretic, and a calcium channel blocker.
    Type: Application
    Filed: September 16, 2022
    Publication date: March 23, 2023
    Inventors: Anthony RODGERS, Stephen MacMAHON
  • Patent number: 11478462
    Abstract: Provided herein are pharmaceutical compositions that are useful for the treatment of hypertension comprising an angiotensin II receptor blocker, a diuretic, and a calcium channel blocker.
    Type: Grant
    Filed: September 8, 2020
    Date of Patent: October 25, 2022
    Assignee: THE GEORGE INSTITUTE FOR GLOBAL HEALTH
    Inventors: Anthony Rodgers, Stephen MacMahon
  • Publication number: 20220226316
    Abstract: Provided herein are pharmaceutical compositions that are useful for the treatment of diabetes and associated conditions, diseases, and disorders.
    Type: Application
    Filed: November 15, 2021
    Publication date: July 21, 2022
    Inventors: Stephen MacMAHON, Anthony RODGERS
  • Publication number: 20220226315
    Abstract: Provided herein are pharmaceutical compositions that are useful for the treatment of diabetes and associated conditions, diseases, and disorders.
    Type: Application
    Filed: November 15, 2021
    Publication date: July 21, 2022
    Inventors: Stephen MacMAHON, Anthony RODGERS